Percentage ownership determines your economic share of the company's eventual value; board control determines your ability to make decisions, including decisions about your own continued role as CEO. A founder with 35% ownership and board control is far more secure than a founder with 55% ownership who faces a board configured to remove them at the lead investor's direction.
In my experience, the conflation of ownership with control is one of the most common misunderstandings founders carry into Series A negotiations. They are different mechanisms with different consequences. Ownership determines your economic outcome: if the company sells for $100 million and you own 35%, you receive $35 million (subject to liquidation preferences and other waterfall mechanics). Board control determines your operational outcome: who runs the company, who can be hired and fired, which strategic decisions get made, which offers to buy the company get accepted. A board-controlled founder with minority ownership can still build and lead the company they envisioned. A founder with majority ownership who has lost board control can be removed as CEO by a board vote — and in most startup structures, the board can fire you as CEO without stockholder approval. The difference matters most in adversarial situations: a board that wants to replace you can do so whether you own 20% or 50%, if the board has the votes. The scenarios in which board composition becomes outcome-determinative include: CEO performance disputes between the founder and the lead investor; disagreements about whether to sell the company; disputes about the terms of a subsequent financing; and any situation in which the board's view of the right path diverges from the founder's. Those situations are more common than founders expect, and the board structure they agreed to at Series A is what determines who wins them.
The most common Series A board structure is a five-member board: two founders (or one founder and one other common stockholder director), two investor directors (one for each significant investor, or two seats for the lead if there is one lead investor), and one independent director who is mutually agreed. This 2-2-1 structure gives founders a working majority if the independent aligns with them, but leaves them at risk if the independent aligns with investors.
The 2-2-1 board structure has become the market standard at Series A for a reason — it represents a negotiated balance between founder control and investor oversight that both sides can accept. The two founder seats are typically held by the CEO and either the CTO or another co-founder with a significant equity stake. The two investor seats are held by the lead partner from the investing firm. The fifth seat — the independent director — is nominally independent but is typically suggested by the lead investor and approved by mutual consent. The practical significance of the independent is significant: in a 2-2 deadlock, the independent's vote determines the outcome. In the more common scenario where three votes are needed for a board action, the independent's alignment determines which side prevails on contested decisions. I advise founders to think carefully about two things regarding the independent director. First, the process for selecting them: mutual consent is better than investor nomination, because it ensures the founder has genuine input into who fills this swing seat. Second, the provision for their replacement: if the current independent resigns or is removed, how is the successor selected? Provisions that give the investor the right to fill a vacated independent seat can convert a 2-2-1 board into a 3-2 investor-controlled board without any additional financing.
Series A investors typically request board seats, protective provisions (veto rights over defined actions), information rights, observer rights, and anti-dilution protections. Board seats and protective provisions are the most consequential — the board seat gives direct governance participation, and protective provisions create effective veto rights over the company's most important decisions regardless of board composition.
Institutional venture investors have developed standard requests for board governance rights that are well understood in the market, and I typically advise founders to distinguish between the rights that are genuinely standard — and therefore not worth fighting — and the rights that represent incremental asks that can be negotiated. The rights that are genuinely standard at Series A include: one board seat for the lead investor (two if the lead is investing 60% or more of the round and there are no other institutional investors); standard protective provisions for the preferred stock class; information rights including quarterly financials, annual audited financials, and an annual operating plan; and standard anti-dilution provisions (weighted average, not full ratchet). The rights that are not standard and that founders should push back on include: a second investor board seat when the lead is not the only institutional investor; broad observer rights for multiple partners at the investing firm; consent rights over officer hires and compensation that go beyond the CEO level; budget approval rights that give the board or the lead investor the right to approve annual operating plans rather than just review them; and any provision that gives the investor the right to appoint the independent director rather than requiring mutual consent.
The most important negotiations for founder board control are: limiting the investor to one board seat rather than two, ensuring the independent director requires mutual consent for appointment and replacement, tying the investor's second seat (if granted) to a financing threshold rather than making it permanent, and ensuring the investor's observer rights do not expand into voting rights without the founder's affirmative consent.
Negotiating board composition is a negotiation about information, power, and precedent all at once, and I typically advise founders to approach it with a clear-eyed view of what they are trading and why. The most valuable protection is the limitation to one investor seat at Series A. If the lead investor holds only one board seat, the 2-1-1 structure (two founders, one investor, one independent) gives founders a working majority regardless of how the independent votes. Investors understand this and often push for a second seat or for broad observer rights for additional partners. I advise founders to resist both: the second seat converts the board to 2-2-1 where the independent becomes the swing vote, and observer rights for multiple partners create a governance dynamic that often functions like additional board seats in practice. On the independent director: the selection process and the replacement process are both important. "Mutual consent" means neither side can install an independent over the other's objection, which is the right standard. "Investor approval with founder consent" or "investor nomination with founder veto" sounds similar but is meaningfully weaker because it sets the investor as the default proposer. On subsequent rounds: founders should push for sunset provisions that automatically convert board seats to observer rights if an investor's ownership falls below a threshold, which prevents board composition from calcifying in ways that give declining investors governance authority disproportionate to their economic stake.
The most dangerous protective provisions are those that give investors effective veto rights over: hiring and firing the CEO, issuing new equity, selling the company or its assets, approving annual budgets, and taking on debt. These provisions can give investors de facto control over the company's most consequential decisions even when the investor does not have a board majority.
Protective provisions — also called major decision provisions or special voting rights — are the preferred stock's right to approve or veto defined categories of company action. They apply as a separate consent right, independent of the board vote, which means a single investor can block an action that the entire board has approved. Understanding which protective provisions are standard versus aggressive is critical, because founders who negotiate hard on board composition and then concede on protective provisions may have given back more than they won. Standard protective provisions that founders should not fight include: prohibition on authorizing a new class of stock senior to or on parity with the preferred; prohibition on amending the company's certificate of incorporation in ways that adversely affect the preferred; prohibition on increasing the authorized number of shares of preferred; prohibition on dissolving or liquidating the company. These are standard protections for the investor's economic interest and are universally required. The provisions founders should negotiate carefully are: consent rights over annual budgets (which can give investors veto over operational decisions disguised as financial oversight); consent rights over officer hires above specified compensation thresholds (which can give investors the ability to block the hiring of a new CFO or VP of Engineering); consent rights over any equity issuance (which, if drafted broadly, can give investors the ability to block a follow-on financing); and consent rights over the acquisition of any business, which can block strategic decisions the founders want to make. The goal is protective provisions that protect the investor's economic position without giving them operational veto rights that are indistinguishable in practice from board control.
Board control typically erodes with each subsequent financing unless founders negotiate explicitly to preserve it. Series B investors often request a board seat in addition to any seats held by Series A investors, which converts a 2-2-1 board to a 2-3-1 or 2-2-2 structure where founders no longer have a path to majority. Founders who do not address board governance proactively at each round often find themselves in a minority board position by Series C.
I typically advise founders who are negotiating their Series A to think two rounds ahead — not because they should try to lock in Series B and C terms now, but because understanding the trajectory helps them identify which Series A provisions will compound most adversely over time. The most important provision to address is board composition upon subsequent financings. Many Series A term sheets are silent on what happens to board composition if the company raises a Series B from a different investor. If the Series A documents don't address this, the Series B investor's term sheet will request a board seat, and the founders will negotiate from a position where the Series A investor has an established seat and the Series B investor is asking for one. By the time the negotiation is complete, founders are often in a 2-3-1 or 2-4-1 structure with no ability to recover a majority. Founders should negotiate at Series A for a provision that governs what happens to board composition in subsequent rounds: a commitment that total investor board representation will not exceed three seats across all series; a requirement that new investor seats come at the cost of converting an existing investor seat to observer status; or an explicit statement that the 2-2-1 structure is intended to persist through Series B. None of these provisions are standard, but they are negotiable with investors who understand the long-term incentive alignment between founders and investors requires founders to remain genuinely in control of the company they are building.
Founders should never agree to: a board structure that gives investors an immediate majority; an independent director selection process that gives the investor unilateral appointment rights; protective provisions that require investor consent for operational decisions like officer hires and annual budgets; and any provision that allows investors to convert observer seats to voting seats without founder consent.
In my years of advising founders through Series A negotiations, I've assembled a short list of provisions I consider non-negotiable regardless of the investor's reputation or the terms of the financing. First, never agree to a board structure where investors hold a majority on closing day. A 3-2 investor-controlled board at Series A is not market standard — it is an aggressive ask that some investors make and that inexperienced founders sometimes accept. If the investor requires board control as a condition of investing, that tells you something important about their intentions for your company. Second, never agree to an independent director selection process where the investor has unilateral appointment rights without your consent. The independent director is the swing vote in a 2-2-1 board, and ceding the right to appoint them is functionally the same as giving the investor a majority. Third, never agree to protective provisions that require investor consent for normal operational decisions — annual budget approval, officer compensation above an arbitrary threshold, any equity issuance regardless of size. These provisions convert a governance role into a management role, and they create friction that slows down the company without providing any meaningful investor protection. Fourth, never agree to provisions that allow observer seats to convert to voting seats without a new investment or financing event. Observer rights should be a surveillance mechanism, not a path to governance control. Any provision that blurs the line between observation and voting should be revised or removed.
The board governance conversation at Series A is the most important one you will have in your company's early life, and it deserves as much preparation and attention as the valuation negotiation. In my experience, the founders who regret their Series A terms most are not the ones who got a lower valuation than they wanted — they are the ones who accepted board structures that gave them no path to prevailing in a governance dispute with their lead investor. Understand what a board majority actually means, understand the real-world function of protective provisions, and think carefully about the independent director process. The one hour you spend negotiating the board composition section of your term sheet is worth more than the ten hours you spent on the option pool shuffle.
Gurpreet S. Bal is a Partner at Foley and Lardner LLP in Silicon Valley, where he advises startups, founders, and investors on SAFE financings, venture capital rounds, mergers and acquisitions, acquihires, and IPOs. He has represented clients in hundreds of transactions with aggregate deal value exceeding $60 billion across AI, semiconductors, fintech, and emerging technology. Prior to his career as a corporate lawyer and transaction advisor, he served with the U.S. Department of Justice and as an international and cross-border tax advisor at a Big 4 accounting firm.